ASMANEX (MOMETASONE FUROATE)
ASMANEX (MOMETASONE FUROATE) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: ASMANEX; Generic name: MOMETASONE FUROATE; Manufacturer: Organon LLC.
| Brand name | ASMANEX |
|---|---|
| Generic name | MOMETASONE FUROATE |
| Manufacturer | Organon LLC |
| Used for | 1 INDICATIONS AND USAGE ASMANEX ® TWISTHALER ® is indicated for the maintenance treatment of asthma as prophylactic therapy in adult and pediatric patients 4 years of age and older. Limitations of Use ASMANEX TWISTHALER is not indicated for the relief of acute bronchospasm. ASMANEX TWISTHALER is not indicated in children less than 4 years of age. ASMANEX TWISTHALER is a corticosteroid indicated for maintenance treatment of asthma as prophylactic therapy in patients 4 years of age and older. ( 1 ) Limitations of Use: ASMANEX TWISTHALER is not indicated for the relief of acute bronchospasm ( 1 , 5.2 ) or in children less than 4 years of age ( 1 , 8.4 ). |
| Dosage | 2 DOSAGE AND ADMINISTRATION Administration Information Administer ASMANEX TWISTHALER by the orally inhaled route only. Instruct patients to inhale rapidly and deeply. After administration, advise patients to rinse the mouth with water and spit out contents without swallowing. Individual patients will experience a variable time to onset and degree of symptom relief. Maximum benefit may not be achieved for 1 to 2 weeks or longer after initiation of treatment. After asthma stability has been achiev |
| Active ingredient(s) | MOMETASONE FUROATE |
| Route | RESPIRATORY (INHALATION) |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=10b36fb2-6b0d-4f20-b197-3564d6f594b9 |